We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $603M Turnover 72.85%
1-Year Est. Return 31.99%
This Fund
S&P 500
This Quarter Est. Return
+17.93%
1 Year Est. Return
+31.99%
3 Year Est. Return
+63.98%
5 Year Est. Return
+46.87%
10 Year Est. Return
+296.03%
AUM
$603M
AUM Growth
+$31.7M
Cap. Flow
-$13.3M
Cap. Flow %
-2.2%
Top 10 Hldgs %
4.32%
Holding
1,374
New
518
Increased
179
Reduced
194
Closed
483
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Industrials 17.11%
3 Financials 15.01%
4 Healthcare 13.93%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NBHC icon
1176
National Bank Holdings
NBHC
$1.63B
– –
-9,635
Closed -$369K –
NBIX icon
1177
Neurocrine Biosciences
NBIX
$16.7B
– –
-5,793
Closed -$746K –
NCNO icon
1178
nCino
NCNO
$2.4B
– –
-49,480
Closed -$714K –
NEM icon
1179
Newmont
NEM
$126B
– –
-2,019
Closed -$208K –
NFG icon
1180
National Fuel Gas
NFG
$6.98B
– –
-7,236
Closed -$687K –
NHI icon
1181
National Health Investors
NHI
$3.5B
– –
-5,975
Closed -$492K –
NICE icon
1182
Nice
NICE
$5.52B
– –
-4,884
Closed -$531K –
NKTR icon
1183
Nektar Therapeutics
NKTR
$1.27B
– –
-6,871
Closed -$448K –
NMR icon
1184
Nomura Holdings
NMR
$27.5B
– –
-11,354
Closed -$86.5K –
NOC icon
1185
Northrop Grumman
NOC
$74.6B
– –
-1,892
Closed -$1.27M –
NRG icon
1186
NRG Energy
NRG
$18.6B
– –
-15,621
Closed -$2.21M –
NRIX icon
1187
Nurix Therapeutics
NRIX
$1.67B
– –
-14,489
Closed -$213K –
NSIT icon
1188
Insight Enterprises
NSIT
$4.56B
– –
-18,938
Closed -$1.22M –
NTNX icon
1189
Nutanix
NTNX
$15.9B
– –
-20,078
Closed -$762K –
NU icon
1190
Nu Holdings
NU
$58.1B
– –
-17,233
Closed -$233K –
NUVB icon
1191
Nuvation Bio
NUVB
$1.47B
– –
-45,586
Closed -$185K –
NUVL icon
1192
DELISTED
Nuvalent
NUVL
– –
-8,173
Closed -$790K –
NVR icon
1193
NVR
NVR
$16.7B
– –
-75
Closed -$487K –
OBDC icon
1194
Blue Owl Capital
OBDC
$5.36B
– –
-19,238
Closed -$210K –
OGN icon
1195
Organon & Co
OGN
$3.64B
– –
-89,236
Closed -$509K –
OHI icon
1196
Omega Healthcare
OHI
$14.7B
– –
-30,792
Closed -$1.36M –
OLED icon
1197
Universal Display
OLED
$3.98B
– –
-4,980
Closed -$444K –
OLLI icon
1198
Ollie's Bargain Outlet
OLLI
$5.37B
– –
-11,233
Closed -$1.01M –
OMC icon
1199
Omnicom Group
OMC
$23.7B
– –
-9,299
Closed -$700K –
OPEN icon
1200
Opendoor
OPEN
$1.3B
– –
-24,912
Closed -$110K –

Similar funds

Fox Run Management's Q2 2026 Portfolio in Review

As of Q2 2026, Fox Run Management held 1,374 positions worth $603M, up 5.5% from $572M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

Fox Run Management's Q2 2026 filing shows 518 new, 179 increased, 194 reduced and 483 closed positions. Its largest new stake was Zoetis: 29,511 shares worth $2.12M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $7.85M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.

  • Fox Run Management's largest Q2 2026 buy was Zoetis: 29,511 shares worth $2.12M.
  • Fox Run Management added most to Intercontinental Exchange in Q2 2026, an estimated $2.5M increase.
  • Fox Run Management's biggest Q2 2026 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $7.85M.
  • Fox Run Management fully exited Cummins in Q2 2026, selling an estimated $2.64M.
  • Fox Run Management's ten largest holdings make up 4.3% of its $603M portfolio in Q2 2026.
  • Fox Run Management opened 518 new positions and closed 483 in Q2 2026.
  • Fox Run Management's portfolio value rose 5.5% quarter-over-quarter to $603M.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.